Target intelligence / Profile preview

Other messenger RNAs with seed-region complementarity (Off-target mRNAs)

Target
Off-target mRNAs
Molecular classification
Messenger RNA, Nucleic acid
01

Overview

Other messenger RNAs with seed-region complementarity refers to the broad set of unintended transcripts targeted by RNA interference (RNAi) therapeutics, such as siRNAs or miRNA mimics (Jackson et al., 2003, Nature Biotechnology). This phenomenon occurs when the 'seed region'—typically nucleotides 2 through 8 of the small RNA guide strand—finds a complementary match in the 3' untranslated region (UTR) of a non-target mRNA (Birmingham et al., 2006, Nature Methods). Because this binding mimics the natural regulatory mechanism of endogenous microRNAs, it can lead to the degradation or translational repression of hundreds of unintended genes (Filipowicz et al., 2008, Nature Reviews Genetics). In drug discovery, these off-target effects are a significant hurdle, as they can cause cellular toxicity or lead to false-positive results in functional screens (Burchard et al., 2009, Nature Biotechnology). Modern therapeutic design employs chemical modifications, such as 2'-O-methyl substitutions on the ribose ring, and advanced bioinformatic filtering to minimize these interactions and improve the safety profile of RNA-based drugs (Janas et al., 2018, Nature Communications). Consequently, this 'target' is actually a primary source of toxicity that must be avoided rather than a therapeutic objective.

Other names
Off-target transcriptsSeed-matched off-targetsmiRNA-like off-targetssiRNA off-target effects
02

Mechanism of action

Unintended binding of the siRNA or miRNA seed region (nucleotides 2-8) to complementary sequences in the 3' untranslated regions (UTRs) of non-target mRNAs, leading to gene silencing via the RNA-induced silencing complex (RISC).

03

Biological functions

Post-transcriptional gene regulationmRNA degradationTranslational repression
04

Disease associations

Drug-induced toxicityOff-target effects
05

Safety considerations

Unintended gene silencingCellular toxicityHepatotoxicityConfounding experimental phenotypesSaturation of the RNAi machinery
06

Interacting drugs

Small interfering RNA (siRNA)

3 more in the full profile.

07

Biomarkers

Differential gene expression (RNA-seq)Microarray expression profilingReporter gene assays

Beyond the preview

Go deeper on Other messenger RNAs with seed-region complementarity (Off-target mRNAs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Other messenger RNAs with seed-region complementarity (Off-target mRNAs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call